The Journal for Nurse Practitioners
Volume 5, Issue 10 , Pages 733-741 , November 2009

Links Between Infectious Diseases and Cardiovascular Disease: A Growing Body of Evidence

  • Kim Curry

      Affiliations

    • Kim Curry, PhD, ARNP, is an assistant professor in the department of nursing at the University of Tampa in Florida.
    • ,
  • Lauren Lawson

      Affiliations

    • Lauren Lawson, PhD, RN, is an associate professor in the department.

References 

  1. Mattila KJ , Nieminen MS , Valtonen VV , et al.   Association between dental health and acute myocardial infarction . Br Med J . 1989;298:779–781
  2. Loesche WJ . Microbiology of dental decay and periodontal disease . In: Baron  editors. Medical microbiology . 4th ed.. Galveston, TX: The University of Texas Medical Branch at Galveston; 1996; [online text].
  3. Genco R , Offenbacher S , Beck J . Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms . J Am Dent Assoc . 2002;133:14S–22S
  4. DeStefano F , Anda R , Kahn H , et al.   Dental disease and risk of coronary heart disease and mortality . Br Med J . 1993;306:688–691
  5. Beck J , Garcia R , Heiss G , et al.   Periodontal disease and cardiovascular disease . J Periodontol . 1996;67:1123–1137
  6. Wu T , Trevisan M , Genco R , et al.   Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen . Am J Epidemiol . 2000;151(3):273–282
  7. Glurich I , Grossi S , Albini B , et al.   Systemic inflammation in cardiovascular and periodontal disease: comparative study . Clin Diagn Lab Immunol . 2002;3:425–432
  8. Haraszthy V , Zambon J , Trevisan M , et al.   Identification of periodontal pathogens in atheromatous plaques . J Periodontol . 2000;71:1554–1560
  9. Chong P , Kezele B . Periodontal disease and atherosclerotic cardiovascular disease: confounding effects or epiphenomenon? . Pharmacotherapy . 2000;20(7):805–818
  10. Centers for Disease Control and Prevention  . Chlamydia pneumoniae. Disease listing, October 6, 2005 . Available at: www.cdc.gov/ncidod/DBMD/diseaseinfo/chlamydiapneumonia_t.htm Last accessed July 21, 2008.
  11. Campbell L , Kuo C , Grayston J . Chlamydia pneumoniae and cardiovascular disease. Emerging Infect Dis . Available at: http://www.cdc.gov/ncidod/EiD/vol4no4/Campbell.htm Accessed July 26, 2008.
  12. Saikku P , Leinonen M , Mattila K , et al.   Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction . Lancet . 1988;2:983–986
  13. Larsen M , Moern B , Fuller A , et al.   Chlamydia pneumoniae and cardiovascular disease . Med J Austral . 2002;177(10):558–562
  14. Arcari C , Gaydos C , Nieto F , et al.   Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the united states military: the importance of timing of exposure measurement . Clin Infect Dis . 2005;40:1123–1132
  15. Ewald P , Cochran G . Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment . J Infect Dis . 2000;181(Suppl 3):394–401
  16. Leinonen M . Chlamydia pneumoniae and other risk factors for atherosclerosis . J Infect Dis . 2000;181(Suppl):S414–S416
  17. Pellicano R , Peyre S , Astegiano M , Oliaro E , Fagoonee S , Rizzetto M . Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease . Panminerva Med . 2006;48(4):241–246
  18. Manolakis A , Kapsoritakis A , Potamianos S . A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease . Helicobacter . 2007;12(4):287–297
  19. Berrutti M , Pellicano R , Fagoonee S , et al.   Potential relationship between Helicobacter phylori and ischaemic heart disease: any pathogenic model? . Panminerva Med . 2008;50(20):161–163
  20. Franceschi F , Niccoli G , Ferrante G , et al.   CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases . Atherosclerosis . 2008; July 1; Available at: http://www.ncbi.nlm.nih.gov.esearch.ut.edu/pubmed/18599062 Last accessed August 1, 2008.
  21. Leinonen M , Saiku P . Evidence for infectious agents in cardiovascular disease and atherosclerosis . Lancet . 2002;2:11–17
  22. Minick C , Fabricant C , Fabricant J , et al.   Atheroarteriosclerosis induced by infection with a herpesvirus . Am J Pathol . 1979;96(3):673–706
  23. Zhu J , Quyyumi A , Norma J , et al.   The possible role of hepatitis A virus in the pathogenesis of atherosclerosis . J Infect Dis . 2000;182(6):1583–1587
  24. Gyorkey F , Melnick J , Guinn G , et al.   Herpes viridae in the endothelial and smooth muscle cells of the proximal aorta of atherosclerotic patients . Exp Mol Pathol . 1984;40(3):328–339
  25. Nicholson A , Hajjar D . Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? . Arterioscl Thromb Vasc Biol . 1998;18(3):339–349
  26. Zhu J , Shearer G , Norma J , et al.   Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based difference in inflammation and type of immune response . Circulation . 2000;102(20):2491–2496
  27. Eryol N , Kilic H , Gul A , et al.   Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? . Int Heart J . 2005;46(2):205–209
  28. Gredmark S , Jonasseon L , Van Gosliga D , et al.   Active cytomegalovirus replication in patients with coronary disease . Scand Cardiovasc J . 2007;41(4):230–234
  29. Rothenbacher D , Hoffmeister A , Bode D , et al.   Cytomegalovirus infection and coronary heart disease: results of a German case-control study . Infect Dis . 1999;179(3):690–692
  30. Muhlestein J , Anderson J , Hammond E , et al.   Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model . Circulation . 1998;97(7):633–636
  31. Fong IW , Chiu B , Viira E , Fong MW , Jang D , Mahony J . Rabbit model for Chlamydia pneumoniae infection . J Clin Microbiol . 1997;35(1):48–52
  32. Gieffers J , Solbach W , Maass M . In vitro sucseptibility of Chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells . Cardiovasc Drug Ther . 2001;15(3):259–262
  33. Fujii K , Saito H , Tomioka H , Mae T , Hosoe K . Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648 . Antimicrob Agents Chemother . 1995;39(7):1489–1492
  34. Gurfinkel E , Bozovich G , Daroca A , et al.   Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study . Lancet . 1997;350(9083):404–407
  35. Gupta S , Leatham E , Carrington D , et al.   Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction . Circulation . 1997;96(2):404–407
  36. Muhlestein J , Anderson J , Carlquist J , et al.   Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study . Circulation . 2002;102(15):1755–1760
  37. Higgins J . Chlamydia pneumoniae and coronary artery disease: the antibiotic trials . Mayo Clin Proc . 2003;78(3):321–332
  38. Meier C , Derby L , Jick S , et al.   Antibiotics and risk of subsequent first-time acute myocardial infarction . JAMA . 1999;281(5):427–431
  39. Jackson L , Smith N , Heckbert S , et al.   Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline . Emerging Infect Dis . 1999;5(2):281–284
  40. O'Connor C , Dunne M , Pfeffer M , et al.   Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial . JAMA . 2003;290(11):1459–1466
  41. Stone A , Mendall M , Kaski J-C , et al.   Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA) . Circulation . 2002;106(10):1219–1223
  42. Cannon CP , Braunwald E , McCabe CH , et al.   Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome . N Engl J Med . 2005;352(16):1646–1654
  43. Jespersen C , Als-Nielsen B , Damgaard M , et al.   Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial . Br Med J . 2006;332(7532):22–27
  44. Wells BJ , Mainous AG , Dickerson LM . Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials . Arch Intern Med . 2004;164(19):2156–2161
  45. Andraws R , Berger JS , Brown DL . Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials . JAMA . 2005;293:2641–2647
  46. Watson C , Alp NJ . Role of Chlamydia pneumoniae in atherosclerosis . Clin Sci . 2008;114:509–531
  47. Abou-Raya A , Abou-Raya S . Inflammation: a pivotal link between autoimmune diseases and atherosclerosis . Autoimmun Rev . 2006;5:331–337 Available from www.sciencedirect.com Accessed April 5, 2008.
  48. Lowe G . Dental disease, coronary heart disease and stroke, and inflammatory markers: what are the associations, and what do they mean? . Circulation . 2004;109:1076–1078

 The authors, reviewers, and editors all report no financial relationships that pose a conflict of interest. The authors do not present any off-label or non-FDA-approved recommendations for treatment. There is no implied endorsement by NPA, MNA, or ANCC of any commercial products mentioned in this article.In compliance with national ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.

PII: S1555-4155(08)00639-9

doi: 10.1016/j.nurpra.2008.12.006

The Journal for Nurse Practitioners
Volume 5, Issue 10 , Pages 733-741 , November 2009

Article Tools